Adeno-associated virus (AAV) is a prominent gene therapy delivery vehicle abundantly used in clinical trials worldwide. However, the restricted cell and tissue tropism of many of the serotypes limit their applicability to treating multisystem diseases. To overcome these limitations, Creative Biolabs offers high-quality AAV capsid modification services to promote the development of global customers' projects.